Suchergebnisse - "O'Day, Steven J"

PubPharm (13)

1

The Society for Immunotherapy of Cancer perspective on regulation of interleukin-6 signaling in COVID-19-related systemic inflammatory response

enthalten in: Journal for immunotherapy of cancer | 2020

von Arnaldez, F. | O'Day, S. | Drake, C. | +8

2

Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002) : a randomised, controlled, phase 2 trial

enthalten in: The Lancet. Oncology | 2015

von Ribas, A. | Puzanov, I. | Dummer, R. | +33

CommentIn: Lancet Oncol. 2015 Aug;16(8):873-4. - PMID 26115798

3

Development of ipilimumab : a novel immunotherapeutic approach for the treatment of advanced melanoma

enthalten in: Annals of the New York Academy of Sciences | 2013

von Wolchok, J. | Hodi, F. | Weber, J. | +9

4

Clinical and pharmacologic evaluation of two dose levels of intetumumab (CNTO 95) in patients with melanoma or angiosarcoma

enthalten in: Investigational new drugs | 2012

von O'Day, S. | Pavlick, A. | Albertini, M. | +7

5

Safety and clinical activity of ipilimumab in melanoma patients with brain metastases : retrospective analysis of data from a phase 2 trial

enthalten in: Melanoma research | 2011

von Weber, J. | Amin, A. | Minor, D. | +3

6

Systemic treatment of metastatic melanoma : new approaches

enthalten in: Journal of surgical oncology | 2011

von Hamid, O. | Boasberg, P. | Rosenthal, K. | +1

7

A phase II multicenter study of ipilimumab with or without dacarbazine in chemotherapy-naïve patients with advanced melanoma

enthalten in: Investigational new drugs | 2011

von Hersh, E. | O'Day, S. | Powderly, J. | +7

8

Ipilimumab efficacy and safety in patients with advanced melanoma : a retrospective analysis of HLA subtype from four trials

enthalten in: Cancer immunity | 2010

von Wolchok, J. | Weber, J. | Hamid, O. | +9

CommentIn: Immunotherapy. 2011 May;3(5):595-9. - PMID 21554088

9

Improved survival with ipilimumab in patients with metastatic melanoma

enthalten in: The New England journal of medicine | 2010

von Hodi, F. | O'Day, S. | McDermott, D. | +26

ErratumIn: N Engl J Med. 2010 Sep 23;363(13):1290

10

Ipilimumab monotherapy in patients with pretreated advanced melanoma : a randomised, double-blind, multicentre, phase 2, dose-ranging study

enthalten in: The Lancet. Oncology | 2010

von Wolchok, J. | Neyns, B. | Linette, G. | +14

CommentIn: Lancet Oncol. 2010 Feb;11(2):108-9. - PMID 20152761